ARQT · NASDAQ · Biotechnology

Arcutis Biotherapeutics (ARQT)

Develops ZORYVE topical treatments for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis.

$26.43
vs last close−1.35 (−4.86%)